Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Chemgenex Pharmaceuticals (CXSPY.PK)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: CXSPY.PK
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Analysis - Latest Articles
3 Holiday Stocking Stuffers for Big Gains in 2010
Mike Rabe
•
Nov 02
•
3 Comments
ChemGenex: Late Stage Pipeline Is Undervalued
Mike Rabe
•
Jul 23
•
1 Comment
More articles on CXSPY.PK »
Instablogs
ChemGenex Pharmaceuticals Nears Major Milestones
Fri November 6, 2009
•
Mike Rabe
•
Comment!
3 Holiday Stocking Stuffers for Big Gains in 2010
Sun November 1, 2009
•
Mike Rabe
•
Comment!
Write a post on CXSPY.PK
|
More Instablogs on CXSPY.PK »
Sentiment
What advice would you give to
CXSPY.PK?
119 characters left
What's your view of CXSPY.PK?
Make sure you include CXSPY.PK
140 characters left
|
Settings
Mike Rabe
: Chemgenex (CXS.AS,
CXSPY.PK
) target upgraded to $1.51 price target by
RBS
Morgan. FDA approval expected in March 2010.
Tue, Dec 15, 2009
Mike Rabe
: Chemgenex (CXS.AX,
CXSPY.PK
) comes through again...big European pharma deal. Very solid investment.
Mon, Dec 14, 2009
More StockTalks on CXSPY.PK »